ENVASARC: A pivotal trial of envafolimab and envafolimab in combination with ipilimumab in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy-MedSci.cn - 梅斯（MedSci）

ENVASARC: A pivotal trial of envafolimab and envafolimab in combination with ipilimumab in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy

Riedel, RF; Chawla, SP; Druta, M; Jones, RL; Schuetze, S; Lam, J; Zhuang, DL; Freddo, JL; Adams, BJ; Theuer, CP; D'Angelo, SP

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):

科室
- - 订阅+
  - 更多科室
工具
服务